Links
Organizations
Conferences
Info & Opinion
August 22, 2008
Thursday News
Financial Results From etrials
A few news bulletins on Omnicare, CogState, Octagon Research Solutions, Encorium Group, Ricerca Biosciences and etrials.
Wednesday News
PSI Acquires Thywill
A few news bulletins on Asian Clinical Trials, Suven Life Sciences, LAB Research, Omnicare Clinical Research, Bioanalytical Systems, Acurian, Lux Biosciences, PSI and Thywill
Tuesday News
Lilly, i3 Data Deal
News about Clinipace, ICON, Octagon, drug safety in Canada, DIA leadership, AHIC, Lilly and i3 Statprobe.
Monday News
Covance, Lilly Lab Deal
A few news bulletins on DataTrak, Clinilabs, Covance, Eli Lilly, Phase Forward, Velos, United BioSource Corporation, CogState, Parexel International and Chiltern
Thursday News
eRT Earnings Rise 61%
A few news bulletins on Phase Forward, INC Research, eResearchTechnology, Abingdon Life Sciences, Stason Pharmaceuticals, etrials, and OmniComm.
DataTrak, the Cleveland eclinical suite, announced bleak financial results. Revenues dropped 34 percent to $4.3 million. Writing off the value of its ClickFind acquisition, DataTrak recorded a loss of $18.2 million. “We continue to sign new business with both existing and new customers and were very pleased with the level… more...
Lilly extended a contract with electronic data capture powerhouse Phase Forward. The companies say Lilly has used Phase Forward’s EDC software in over 200 trials. In what appears to be a new development, the Indiana company will be “mandating” the use of Phase Forward’s EDC solution with global service partners.… more...
eResearch Technology said it is optimistic about electronic patient reported outcomes as a business. The comments came in its recent earnings call with Wall Street. “ePRO represents a very small percentage of our revenue base now, but over the long-term, we are optimistic about the ability of ePRO to contribute… more...
inVentiv Health announced two appointments. Dan Rubin has been named president of inVentiv patient outcomes. Norman Stalsberg has been named president of inVentiv strategy & analytics. “Dan and Norman both have outstanding leadership experience and vision, having grown small ventures into thriving businesses. I believe the skills and perspective they… more...
Can the analysis of an electrocardiogram (ECG) waveform be programmed into a computer chip? That’s the claim of Freescale Semiconductor and Monebo Technologies. “We have the technology to provide detailed information to the clinician, enabling physicians to monitor heart patients from a remote location, and also analyze and interpret ECG… more...
CytoDyn picked Target Health for the preparation and electronic filing of CytoDyn’s upcoming FDA application using Target Health’s proprietary electronic case report forms (e*CRF) system, which offers a paperless approach to FDA filings, including submission of electronic INDs and electronic common technical documents (eCTD). Dow Pharmaceutical Sciences, King Pharmaceuticals and… more...
An investor group that includes two former etrials executives—ex-CFO Jim Clark and ex-CEO John Cline—now owns a fifth of the company and is pushing for a new strategy. The group hopes to explore share repurchases and a sale of the technology firm. Here’s a story. PharmaVigilant announced a new version… more...
The FDA is soliciting industry input for a “quality by design” initiative, FDA News reports. Here’s the federal notice. The Associated Press has tabulated the time needed for the FDA to send warning letters over the illegal promotion of off-label uses of prescription drugs. It takes the agency seven months… more...
There is an event dedicated to trials in Central and Eastern Europe (CEE). NextLevel Pharma’s CEE Clinical Development & Outsourcing event will examine regulatory, clinical, outsourcing and environmental factors that can impact the clinical trials landscape in specific locations in CEE. Particular and specific attention will be given to Russia… more...
Intel has entered the healthcare market with a handheld device for patients to use at home. The idea is to help doctors stay abreast of health changes using technology. The new device isn’t specifically targeted for clinical trials, and Intel does not have any track record of developing user interfaces… more...
